Silver Book Fact

Parkinson’s disease is the 2nd-most common neurodegenerative disease in the U.S., second only to Alzheimer’s disease.

Nussbaum, Robert L, and Christopher E Ellis. Genomic Medicine: Alzheimer’s Disease and Parkinson’s Disease. N Engl J Med. 2003; 348(14): 1356-64. http://www.nejm.org/doi/full/10.1056/NEJM2003ra020003

Reference

Title
Genomic Medicine: Alzheimer’s Disease and Parkinson’s Disease
Publication
N Engl J Med
Publication Date
2003
Authors
Nussbaum, Robert L, and Christopher E Ellis
Volume & Issue
Volume 348, Issue 14
Pages
1356-64
URL
Read Full Resource

Categories

  • Cost of Disease
  • Prevalence & Incidence

Related Facts

  • The estimated lifetime risk of developing Alzheimer’s disease is: Nearly 1 in 5 for women (17.2%) One in 10 for men (9.1%)  
  • Compared to a person who does not have dementia, the hospital costs for someone who has been diagnosed with Alzheimer’s disease were, on average, 3.2 times higher.  
  • Alzheimer’s disease cost $203 billion in 2013.  
  • In 2004, total per-person payments for Medicare beneficiaries age 65 and older with Alzheimer’s disease and other dementias (including all sources for health and long-term care) were $33,007–compared to $10,603…  
  • Parkinson’s disease is the 2nd-most common neurodegenerative disease in the U.S., second only to Alzheimer’s disease.